Skip to main content
. 2019 Nov 1;244(18):1608–1618. doi: 10.1177/1535370219885320

Figure 5.

Figure 5.

Interaction between HMGB1 and RvD1 and its receptors. (a) Western blot assay was performed to detect the expression of HMGB1 in CNE2 cells after treatment with RvD1 (100 nM). The experiment was performed in triplicate. (b) Quantitative analyses of expression of HMGB1 in CNE2 cells. Data are expressed as mean ± SD, *P < 0.05. The data represent the average of three experiments. (c) The expression of ALX/FPR2 and GPR32 after treatment with rhHMGB1 and RvD1. The experiment was performed in triplicate.

HMGB1: high mobility group box 1; RvD1: resolvin D1; FPR2: formyl peptide receptor 2; ALX: lipoxin A4 receptor; GAPDH: glyceraldehyde 3-phosphate dehydrogenase.